LAB PHARMA AS

0160 OSLO

Finances

Share Ownership

Return on Equity

−3 672,22 %

Current Ratio

0,48

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	22 365 000	22 600 000	33 604 000	47 182 000
Net Income	−661 000	−894 000	106 000	3 452 000
Total Assets	4 765 000	4 713 000	5 851 000	8 307 000
Total Equity	18 000	679 000	1 573 000	2 667 000

Income (NOK)	2022	2021	2020	2019
Revenue	22 365 000	22 600 000	33 604 000	47 182 000
Expenditure	24 223 000	23 948 000	34 906 000	42 310 000
Operating Profit	−1 857 000	−1 349 000	−1 304 000	4 872 000
Financial Income	1 510 000	1 238 000	2 265 000	889 000
Financial Costs	500 000	1 035 000	825 000	1 331 000
Financial Balance	1 010 000	203 000	1 440 000	−442 000
Earnings Before Tax	−847 000	−1 146 000	136 000	4 429 000
Tax	−186 000	−252 000	30 000	977 000
Net Income	−661 000	−894 000	106 000	3 452 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	2 498 000	2 327 000	2 078 000	1 940 000
Total Current Assets	2 267 000	2 387 000	3 774 000	6 367 000
Total Assets	4 765 000	4 713 000	5 851 000	8 307 000
Total Retained Equity	−482 000	179 000	1 073 000	2 167 000
Total Equity	18 000	679 000	1 573 000	2 667 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	4 747 000	4 034 000	4 278 000	5 641 000
Total Equity and Debt	4 765 000	4 713 000	5 851 000	8 307 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	21 730 000	21 903 000	32 559 000	46 967 000
Other Income	635 000	696 000	1 044 000	214 000
Revenue	22 365 000	22 600 000	33 604 000	47 182 000
Cost of Goods Sold	3 206 000	2 856 000	3 857 000	4 951 000
Salary Costs	3 354 000	3 343 000	3 492 000	3 951 000
Depreciation	40 000	29 000	32 000	35 000
Impairment	0	0	0	0
Expenditure	24 223 000	23 948 000	34 906 000	42 310 000
Operating Profit	−1 857 000	−1 349 000	−1 304 000	4 872 000
Financial Income	1 510 000	1 238 000	2 265 000	889 000
Financial Costs	500 000	1 035 000	825 000	1 331 000
Financial Balance	1 010 000	203 000	1 440 000	−442 000
Dividends	0	0	1 200 000	2 000 000
Net Income	−661 000	−894 000	106 000	3 452 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	2 199 000	2 024 000	1 784 000	1 626 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	38 000	41 000	32 000	52 000
Total Tangible Assets	38 000	41 000	32 000	52 000
Total Fiancial Fixed Assets	262 000	262 000	262 000	262 000
Total Fixed Assets	2 498 000	2 327 000	2 078 000	1 940 000
Stock	467 000	438 000	415 000	509 000
Total Investments	0	0	0	0
Cash, Bank	997 000	1 586 000	1 327 000	1 863 000
Total Current Assets	2 267 000	2 387 000	3 774 000	6 367 000
Total Assets	4 765 000	4 713 000	5 851 000	8 307 000
Total Equity	18 000	679 000	1 573 000	2 667 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	2 978 000	2 534 000	2 060 000	1 062 000
Unpaid Taxes	434 000	334 000	269 000	342 000
Dividends	0	0	1 200 000	2 000 000
Other Current Debt	1 335 000	1 166 000	549 000	2 237 000
Total Current Debt	4 747 000	4 034 000	4 278 000	5 641 000
Total Equity and Debt	4 765 000	4 713 000	5 851 000	8 307 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−3 672,22 %	−131,66 %	6,74 %	129,43 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	−8,3 %	−5,97 %	−3,88 %	10,33 %
Current Ratio	0,48	0,59	0,88	1,13
Quick Ratio	0,53	0,66	0,98	1,24
Equity Ratio	0	0,14	0,27	0,32
Gross Profit Margin	85,67 %	87,36 %	88,52 %	89,51 %